Matches in SemOpenAlex for { <https://semopenalex.org/work/W1981801627> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W1981801627 endingPage "140" @default.
- W1981801627 startingPage "138" @default.
- W1981801627 abstract "Gefitinib is the first inhibitor of the epidermal growth factor receptor that has shown activity in non–small-cell lung cancer (NSCLC), but its potential value in the treatment of central nervous system (CNS) metastases has been rarely assessed. We report 2 cases of patients with CNS metastases responding to gefitinib and a review of all the cases previously published in the literature. Computerized and manual searches were performed to identify reports of patients with NSCLC with CNS metastases treated with gefitinib. Ten reports including 16 cases were identified. Of 18 patients, which included our 2 cases, 14 (78%) were female and 4 (22%) were male. Histologic type was reported in 15 cases, and 12 of them (80%) were adenocarcinomas. Five patients exhibited a complete response (28%) and the rest were partial responses. In addition, we identified 5 series of NSCLC patients with CNS metastases treated with gefitinib, and response rates ranged from 0 to 33%. In conclusion, gefitinib can induce long-lasting responses in NSCLC patients with CNS metastases. Responses have been most frequently observed in female patients with adenocarcinoma. Gefitinib may be an effective and well-tolerated option for selected NSCLC patients with CNS metastases." @default.
- W1981801627 created "2016-06-24" @default.
- W1981801627 creator A5000490377 @default.
- W1981801627 creator A5028200237 @default.
- W1981801627 creator A5028314830 @default.
- W1981801627 creator A5040129979 @default.
- W1981801627 creator A5040905146 @default.
- W1981801627 creator A5043781872 @default.
- W1981801627 creator A5090757835 @default.
- W1981801627 date "2005-09-01" @default.
- W1981801627 modified "2023-10-17" @default.
- W1981801627 title "Activity of Gefitinib in Central Nervous System Metastases in Patients with Non–Small-Cell Lung Cancer: Two Case Reports and a Review of the Literature" @default.
- W1981801627 cites W2001133071 @default.
- W1981801627 cites W2002884377 @default.
- W1981801627 cites W2025294744 @default.
- W1981801627 cites W2090036185 @default.
- W1981801627 cites W2114825062 @default.
- W1981801627 cites W2117626696 @default.
- W1981801627 cites W2124224831 @default.
- W1981801627 cites W2129455899 @default.
- W1981801627 cites W2140313211 @default.
- W1981801627 doi "https://doi.org/10.3816/clc.2005.n.030" @default.
- W1981801627 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16179102" @default.
- W1981801627 hasPublicationYear "2005" @default.
- W1981801627 type Work @default.
- W1981801627 sameAs 1981801627 @default.
- W1981801627 citedByCount "11" @default.
- W1981801627 countsByYear W19818016272012 @default.
- W1981801627 countsByYear W19818016272013 @default.
- W1981801627 countsByYear W19818016272015 @default.
- W1981801627 countsByYear W19818016272016 @default.
- W1981801627 countsByYear W19818016272019 @default.
- W1981801627 crossrefType "journal-article" @default.
- W1981801627 hasAuthorship W1981801627A5000490377 @default.
- W1981801627 hasAuthorship W1981801627A5028200237 @default.
- W1981801627 hasAuthorship W1981801627A5028314830 @default.
- W1981801627 hasAuthorship W1981801627A5040129979 @default.
- W1981801627 hasAuthorship W1981801627A5040905146 @default.
- W1981801627 hasAuthorship W1981801627A5043781872 @default.
- W1981801627 hasAuthorship W1981801627A5090757835 @default.
- W1981801627 hasConcept C121608353 @default.
- W1981801627 hasConcept C126322002 @default.
- W1981801627 hasConcept C143998085 @default.
- W1981801627 hasConcept C2776256026 @default.
- W1981801627 hasConcept C2777714996 @default.
- W1981801627 hasConcept C2779438470 @default.
- W1981801627 hasConcept C2780580887 @default.
- W1981801627 hasConcept C2781182431 @default.
- W1981801627 hasConcept C529278444 @default.
- W1981801627 hasConcept C71924100 @default.
- W1981801627 hasConceptScore W1981801627C121608353 @default.
- W1981801627 hasConceptScore W1981801627C126322002 @default.
- W1981801627 hasConceptScore W1981801627C143998085 @default.
- W1981801627 hasConceptScore W1981801627C2776256026 @default.
- W1981801627 hasConceptScore W1981801627C2777714996 @default.
- W1981801627 hasConceptScore W1981801627C2779438470 @default.
- W1981801627 hasConceptScore W1981801627C2780580887 @default.
- W1981801627 hasConceptScore W1981801627C2781182431 @default.
- W1981801627 hasConceptScore W1981801627C529278444 @default.
- W1981801627 hasConceptScore W1981801627C71924100 @default.
- W1981801627 hasIssue "2" @default.
- W1981801627 hasLocation W19818016271 @default.
- W1981801627 hasLocation W19818016272 @default.
- W1981801627 hasOpenAccess W1981801627 @default.
- W1981801627 hasPrimaryLocation W19818016271 @default.
- W1981801627 hasRelatedWork W1602357875 @default.
- W1981801627 hasRelatedWork W1971737397 @default.
- W1981801627 hasRelatedWork W2014330130 @default.
- W1981801627 hasRelatedWork W2027052672 @default.
- W1981801627 hasRelatedWork W2060084543 @default.
- W1981801627 hasRelatedWork W2186047679 @default.
- W1981801627 hasRelatedWork W2802661326 @default.
- W1981801627 hasRelatedWork W2888534976 @default.
- W1981801627 hasRelatedWork W3012491061 @default.
- W1981801627 hasRelatedWork W3037074763 @default.
- W1981801627 hasVolume "7" @default.
- W1981801627 isParatext "false" @default.
- W1981801627 isRetracted "false" @default.
- W1981801627 magId "1981801627" @default.
- W1981801627 workType "article" @default.